Ravinder Dhawan

1.6k total citations
42 papers, 1.3k citations indexed

About

Ravinder Dhawan is a scholar working on Hematology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ravinder Dhawan has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 12 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ravinder Dhawan's work include Multiple Myeloma Research and Treatments (22 papers), Cancer Treatment and Pharmacology (10 papers) and Prostate Cancer Treatment and Research (7 papers). Ravinder Dhawan is often cited by papers focused on Multiple Myeloma Research and Treatments (22 papers), Cancer Treatment and Pharmacology (10 papers) and Prostate Cancer Treatment and Research (7 papers). Ravinder Dhawan collaborates with scholars based in United States, United Kingdom and Belgium. Ravinder Dhawan's co-authors include Karin S. Coyne, Samir Bhattacharyya, Cheryl Dennison Himmelfarb, Andrew R. Lloyd, Manishi Prasad, Zhiyuan Zhou, Christine L. Thompson, Eboo Versi, Ramesh Kumar and Helgi van de Velde and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Ravinder Dhawan

39 papers receiving 1.2k citations

Peers

Ravinder Dhawan
Kelly Hollis United States
John Coombs United States
Joshua P. Slusser United States
Mohsen Shabahang United States
Richard Barron United States
W. Clark United Kingdom
Markus Bredemeier Brazil
Ahmet Alacacıoğlu Türkiye
Sunil V. Patel Canada
Susan G. Barr Canada
Kelly Hollis United States
Ravinder Dhawan
Citations per year, relative to Ravinder Dhawan Ravinder Dhawan (= 1×) peers Kelly Hollis

Countries citing papers authored by Ravinder Dhawan

Since Specialization
Citations

This map shows the geographic impact of Ravinder Dhawan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravinder Dhawan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravinder Dhawan more than expected).

Fields of papers citing papers by Ravinder Dhawan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravinder Dhawan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravinder Dhawan. The network helps show where Ravinder Dhawan may publish in the future.

Co-authorship network of co-authors of Ravinder Dhawan

This figure shows the co-authorship network connecting the top 25 collaborators of Ravinder Dhawan. A scholar is included among the top collaborators of Ravinder Dhawan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravinder Dhawan. Ravinder Dhawan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oh, William, Raymond Miao, Francis Vekeman, et al.. (2017). Patient characteristics and overall survival in patients with post-docetaxel metastatic castration-resistant prostate cancer in the community setting. Medical Oncology. 34(9). 160–160. 15 indexed citations
2.
Ivanova, Jasmina I., Jennifer Sung, Mei Sheng Duh, et al.. (2017). Real-world treatment patterns and effectiveness among patients with metastatic colorectal cancer treated with ziv-aflibercept in community oncology practices in the USA. Medical Oncology. 34(12). 193–193. 19 indexed citations
3.
4.
Oh, William, Ruoyu Miao, Francis Vekeman, et al.. (2016). Treatment Sequences, Patient Characteristics, And Overall Survival Of Patients With Post-Docetaxel Metastatic Castration-Resistant Prostate Cancer In The Community Setting. Value in Health. 19(3). A139–A139. 1 indexed citations
5.
6.
Mehra, Maneesha, Ying Wu, & Ravinder Dhawan. (2012). Healthcare resource use in advanced prostate cancer patients treated with docetaxel. Journal of Medical Economics. 15(5). 836–843. 16 indexed citations
7.
8.
Mehra, Mandeep R., et al.. (2011). Prevalence of prostate cancer (PC) clinical states (CS) in the United States: Estimates using a dynamic progression model.. Journal of Clinical Oncology. 29(15_suppl). 4637–4637. 8 indexed citations
9.
Hornberger, John, et al.. (2010). The cost‐effectiveness of bortezomib in relapsed/refractory multiple myeloma: Swedish perspective. European Journal Of Haematology. 85(6). 484–491. 31 indexed citations
10.
Dimopoulos, Meletios Α., Μαρία Ρούσσου, Konstantinos Zervas, et al.. (2010). Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study. Blood. 116(21). 3027–3027. 3 indexed citations
11.
Liwing, Johan, Ingmar Sandberg, J Aschan, et al.. (2009). PCN86 THE COST-EFFECTIVENESS OF BORTEZOMIB FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA—A NORDIC COMPARISON. Value in Health. 12(7). A273–A273. 2 indexed citations
12.
Lee, Stephanie J., Paul G. Richardson, Pieter Sonneveld, et al.. (2008). Bortezomib is associated with better health‐related quality of life than high‐dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study. British Journal of Haematology. 143(4). 511–519. 60 indexed citations
13.
Viala, Muriel, Asha Bhakar, Christine de la Loge, et al.. (2007). Patient-reported outcomes helped predict survival in multiple myeloma using partial least squares analysis. Journal of Clinical Epidemiology. 60(7). 670–679.e3. 27 indexed citations
14.
Grima, Daniel, et al.. (2006). Considerations in Developing Model-based Economic Evaluations of Glaucoma Treatment. Journal of Glaucoma. 15(6). 541–547. 1 indexed citations
15.
Kim, Sunny H., Mark E. Boye, Samir Bhattacharyya, Karin S. Coyne, & Ravinder Dhawan. (2006). Medical visits among adults with symptoms commonly associated with an overactive bladder. British Journal of Urology. 97(3). 551–554. 4 indexed citations
16.
Himmelfarb, Cheryl Dennison, Manishi Prasad, Andrew R. Lloyd, et al.. (2005). The Health-Related Quality of Life and Economic Burden of Constipation. PharmacoEconomics. 23(5). 461–476. 325 indexed citations
17.
Coyne, Karin S., Zhiyuan Zhou, Samir Bhattacharyya, et al.. (2003). The prevalence of nocturia and its effect on health‐related quality of life and sleep in a community sample in the USA. British Journal of Urology. 92(9). 948–954. 259 indexed citations
18.
Diestelhorst, Michael, et al.. (2003). Persistency and Clinical Outcomes Associated with Latanoprost and Beta-Blocker Monotherapy: Evidence from a European Retrospective Cohort Study. European Journal of Ophthalmology. 13(4_suppl). 21–29. 25 indexed citations
19.
Atkinson, Mark J., et al.. (2003). A new measure of patient satisfaction with ocular hypotensive medications: the Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP).. Health and Quality of Life Outcomes. 1(1). 67–67. 48 indexed citations
20.
Voruganti, Lakshmi N.P., A. George Awad, L. Kola Oyewumi, et al.. (2000). Assessing Health Utilities in Schizophrenia. PharmacoEconomics. 17(3). 273–286. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelly Hollis Breakdown of academic impact, for papers by John Coombs Breakdown of academic impact, for papers by Joshua P. Slusser Breakdown of academic impact, for papers by Mohsen Shabahang Breakdown of academic impact, for papers by Richard Barron Breakdown of academic impact, for papers by W. Clark Breakdown of academic impact, for papers by Markus Bredemeier Breakdown of academic impact, for papers by Ahmet Alacacıoğlu Breakdown of academic impact, for papers by Sunil V. Patel Breakdown of academic impact, for papers by Susan G. Barr
Rankless by CCL
2026